Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylate the 3' hydroxyl group of phosphatidylinositol lipids. They play a crucial role in various cellular processes, including cell growth, proliferation, survival, motility, and intracellular trafficking. PI3Ks are classified into three main classes based on their structure and substrate specificity. The pathway is tightly regulated by opposing lipid phosphatases such as PTEN. Dysregulation of the PI3K pathway is implicated in cancer and other diseases, making it a therapeutic target.
Inhibition of PI3K kinase activity, blocking downstream signaling pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide 3-Kinase Family Protein (PI3K).